Acute Symptomatic Sinus Bradycardia in High-Dose Methylprednisolone Therapy in a Woman With Inflammatory Myelitis: A Case Report and Review of the Literature.
Corticosteroid
bradycardia
clinical practice guideline
myelitis
side effects
Journal
Clinical medicine insights. Case reports
ISSN: 1179-5476
Titre abrégé: Clin Med Insights Case Rep
Pays: United States
ID NLM: 101531893
Informations de publication
Date de publication:
2019
2019
Historique:
received:
09
01
2019
accepted:
15
01
2019
entrez:
5
3
2019
pubmed:
5
3
2019
medline:
5
3
2019
Statut:
epublish
Résumé
High dose corticosteroid therapy is widely used as attack therapy of inflammatory central nervous system disorders and can induce several adverse reactions. Bradycardia is an infrequent event after corticosteroids administration and is often asymptomatic. We report a case of a woman admitted to the neurological department of our hospital for paraesthesias of the lower limbs. She received adiagnosis of inflammatory myelitis and high dose corticosteroid therapy was prescribed. During the therapy she complained of chest tightness, dyspnoea, weakness and malaise. An electrocardiogram revealed sinus bradycardia. A significant increase in body weight, probably due to plasma volume expansion, was detected. Bradycardia and high blood pressure spontaneously resolved in few days. We provide a collection and a statistical analysis of literature data about steroid induced bradycardia. We found that higher total doses are associated with lower pulse rate and symptomatic bradycardia. Bradycardia is more frequent in older patients and those with underlying cardiac disease or with autonomic disturbance. However clinicians must be aware about the occurrence of symptomatic bradycardia in all patients who undergo high dose corticosteroid therapy, not only in those at risk, to early detect and treat this potentially dangerous condition.
Identifiants
pubmed: 30828250
doi: 10.1177/1179547619831026
pii: 10.1177_1179547619831026
pmc: PMC6390212
doi:
Types de publication
Case Reports
Langues
eng
Pagination
1179547619831026Déclaration de conflit d'intérêts
Declaration of conflicting interests:The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Références
Am J Kidney Dis. 1998 Jul;32(2):E4
pubmed: 10074612
FEBS Lett. 1999 Dec 24;464(1-2):9-13
pubmed: 10611474
Arch Intern Med. 2001 Jul 23;161(14):1778-9
pubmed: 11485514
Int J Dermatol. 2005 Apr;44(4):285-8
pubmed: 15811078
Arch Dis Child. 2005 Oct;90(10):1096-7
pubmed: 16177169
Tex Heart Inst J. 2006;33(1):40-7
pubmed: 16572868
Am J Nephrol. 1990;10(3):231-6
pubmed: 1696428
J Clin Rheumatol. 2004 Aug;10(4):230
pubmed: 17043517
Pediatrics. 2007 Mar;119(3):e778-82
pubmed: 17308245
J Pediatr Hematol Oncol. 2008 Feb;30(2):119-20
pubmed: 18376262
Anesth Analg. 1991 Oct;73(4):385-90
pubmed: 1897764
J Neurol Sci. 2011 Oct 15;309(1-2):75-8
pubmed: 21831398
Arab J Nephrol Transplant. 2012 Jan;5(1):47-9
pubmed: 22283866
J Emerg Med. 2013 Sep;45(3):e55-8
pubmed: 23827163
Discov Med. 2013 Oct;16(88):167-77
pubmed: 24099672
Br J Anaesth. 2013 Dec;111(6):1025-6
pubmed: 24233311
J Med Case Rep. 2015 Sep 24;9:216
pubmed: 26400725
Can Pharm J (Ott). 2015 Sep;148(5):235-40
pubmed: 26445579
Case Rep Cardiol. 2016;2016:9785467
pubmed: 27999689
Scand J Rheumatol. 1986;15(3):302-4
pubmed: 3798047
Proc Soc Exp Biol Med. 1983 Jul;173(3):338-43
pubmed: 6867008
J Rheumatol. 1998 Oct;25(10):1995-2002
pubmed: 9779857
Nephron. 1998 Dec;80(4):484
pubmed: 9832654